|
市場調査レポート
商品コード
1276433
医療用放射線検出器の世界市場規模、シェア、産業動向分析レポート:製品別、タイプ別(ガス充填検出器、シンチレーション検出器、半導体検出器)、最終用途別、地域別展望と予測、2023~2029年Global Medical Radiation Detection Market Size, Share & Industry Trends Analysis Report By Product, By Type (Gas-filled Detectors, Scintillators and Solid-state), By End-Use, By Regional Outlook and Forecast, 2023 - 2029 |
||||||
医療用放射線検出器の世界市場規模、シェア、産業動向分析レポート:製品別、タイプ別(ガス充填検出器、シンチレーション検出器、半導体検出器)、最終用途別、地域別展望と予測、2023~2029年 |
出版日: 2023年04月28日
発行: KBV Research
ページ情報: 英文 214 Pages
納期: 即納可能
|
医療用放射線検出器市場規模は、2029年には15億米ドルに達し、予測期間中にCAGR7.7%の市場成長率で上昇すると予測されています。
放射線モニタリング技術は、世界中で原子力発電所の建設が進むにつれ、需要が高まっています。これらの発電所の製品別は、ヘルスケア部門に応用することができます。病院では、患者に供給される薬用アイソトープを利用して、画像診断装置の構築もサポートしています。
人工放射線源から人が受ける線量の大部分は、X線診断と腫瘍学やその他の重要な疾患における放射性同位元素を用いた治療によるものです。さらに、将来的には放射性元素を用いた診断・治療技術も利用される予定です。放射線(ラジオアイソトープ)療法は、現在でもがんの治療に使われる主な方法の一つです。ベンダーは、医療施設のスタッフに対する放射線の有害な影響を軽減するために、個人線量計や個人用線量管理のための自動システムを供給しています。メーカーや研究者は、市場のリーダーとしての地位を維持するために、革新的な技術を商品に取り入れています。
COVID-19影響度分析
パンデミックは、画像診断検査の実施方法を変化させました。多くの医療施設が、ポータブルX線装置の採用や、撮影時に部屋にいる医療スタッフの数を減らすなど、COVID-19感染の危険性を下げるための新しい方針を実施しました。このような変化により、様々な状況に対応できるモバイル型やハンドヘルド型の医療用放射線検出ツールの需要が高まっています。これらの要素を考慮すると、医療用放射線検出器市場はCOVID-19の普及から大きな恩恵を受けていると言えるでしょう。
市場成長要因
世界のがん患者の増加
近年、さまざまながんの治療、発見、予防が飛躍的に進歩しています。がんの治療には、手術、化学療法、放射線療法、生物学的療法、ホルモン療法などが用いられています。ドキソルビシンは頻繁に処方される化学療法薬で、いくつかの腫瘍タイプの治療に使用されています。酸化ストレスは、腎臓、心臓、脳に影響を与えます。転移性乳がんにおける化学療法薬物耐性は、効果的な治療を行う上で未だに問題になっています。その結果、この要素が医療用放射線検出器市場の燃料となっています。
放射線治療と核医学の利用拡大
機器、IT、核医学の手順は、過去10年間で劇的に変化しています。がんや循環器疾患など多くの病気の診断や治療に核医学が使われるようになったため、放射線検出、モニタリング、安全システムのニーズが高まっているのです。核医学で使用される検出器には、ガス充填検出器、シンチレーション検出器、半導体検出器などの種類があります。これらの要因を考慮すると、放射線療法と核医学の使用量の増加は、市場の拡大をサポートすると予測されます。
市場抑制要因
厳しい規制義務
原子力規制委員会(NRC)、全米放射線防護委員会(NCRP)、食品医薬品局(FDA)、国際放射線防護委員会(ICRP)、米国エネルギー省(DOE)などが放射線防護基準を制定し、各国当局に認知されています。さらに、これらの部門は、医療用放射線の識別、モニタリング、および安全製品を承認するための複数のプロトコルを確立しています。しかし、このような厳しい規制があるため、製品の承認手続きにかかる期間が長くなってしまいます。したがって、厳しい安全規制が製品の発売や開拓を遅らせる可能性があり、市場拡大の妨げとなることが予想されます。
タイプ別展望
医療用放射線検出器市場は、タイプ別にガス充填検出器、シンチレーション検出器、半導体検出器に分類されます。半導体セグメントは、2022年の医療用放射線検出器市場でかなりの収益シェアを占めています。電離放射線は、半導体検出器を用いて検出することができます。半導体検出器は、入射放射線のかなりの部分を電気信号に変えることができるので、非常に効果的です。このため、非常に低いレベルの放射線でも正確に検出することができます。例えば、米国原子力規制委員会は、低エネルギーのガンマ線を識別する上で、半導体検出器はガス充填検出器より優れていると主張しています。
製品の展望
医療用放射線検出器市場は、製品別に、個人線量計、プロセス線量計、表面汚染モニター、その他に分類されます。2022年、医療用放射線検出器市場では、個人線量計セグメントが最大の収益シェアを示しました。個人線量計は、持ち運びが可能で簡単に使用できるなどの特長があるため、人気が高まっています。放射線被曝が懸念される地域で働く労働者は、個人線量計で被曝レベルを監視しています。
最終用途の展望
医療用放射線検出器市場は、最終用途別に病院、外来手術センター、画像診断センター、在宅ケアに分けられます。2022年の医療用放射線検出器市場は、病院分野が最大の収益シェアを占めています。CTスキャン、X線、PETスキャンなどの医療用画像処理に対するニーズが高まっています。これは、高齢者人口の増加や慢性疾患の増加によるものです。医療用放射線検出器は、患者が適切な量の放射線を受けられるようにし、過度の被ばくを防ぐために、これらの作業において非常に重要です。
地域別の展望
地域別に見ると、医療用放射線検出器市場は北米、欧州、アジア太平洋、LAMEAで分析されています。2022年、北米地域は最も高い収益シェアを獲得し、医療用放射線検出器市場をリードしました。この背景には、治療中に電離放射線を浴びることで起こりうる危険に対する不安が高まっていることがあります。その結果、放射線安全に対する規制機関や医療機関の関心は高まっています。このため、放射線レベルを正しく測定し、患者の安全性を向上させるために、医療用放射線検出器のニーズが高まっています。
List of Figures
The Global Medical Radiation Detection Market size is expected to reach $1.5 billion by 2029, rising at a market growth of 7.7% CAGR during the forecast period.
A medical device that finds radiation is called a medical radiation detector. An individual is more likely to develop several lethal diseases when exposed to radiation over a long period. The need for technology that can gauge how much radiation is building up inside the body grows. The radiation portal monitor (RPM), handheld survey meter (HSM), personal radiation detector (PRD), and radiation isotope identification device (RIID) are a few of the important detectors for spotting radioactive materials and ionizing radiation.
As technology develops, a variety of radiation-detecting tools might be made accessible for use at home. Gamma rays are the most hazardous external radioactive threat, and dosimeters are medical radiation detectors that can find them. Radiation in various forms is utilized for both medical diagnosis and treatment. However, exposure must be carefully managed to ensure that the benefits to patients outweigh the hazards because all types have the potential to be hazardous.
Radiation monitoring technology is in greater demand as more nuclear power plants are built worldwide. These power plants' byproducts can be applied to the healthcare sector. Hospitals also support the building of diagnostic imaging equipment by using medicinal isotopes supplied to patients.
The majority of the dose a person receives from man-made radiation sources comes from X-ray diagnostics and therapies using radioisotopes in oncology and some other critical disorders. Additionally being used are the future radioactive element-based diagnostic and treatment techniques. Radiation (radioisotope) therapy is still one of the main methods used to treat cancer. Market vendors are supplying personal dosimeters and automated systems for personal dosage control to lessen the harmful effects of radiation on the staff of healthcare facilities. Manufacturers and researchers are incorporating innovative technology into their goods to maintain their position as market leaders.
COVID-19 Impact Analysis
The pandemic has changed how diagnostic imaging tests are carried out. Numerous healthcare facilities have implemented new policies to lower the danger of COVID-19 transmission, like adopting portable X-ray machines and reducing the number of healthcare staff in the room while imaging is done. These alterations have increased the demand for mobile and handheld medical radiation detection tools that can be applied in various circumstances. In light of these elements, the medical radiation detection market has significantly benefited from the widespread of COVID-19.
Market Growth Factors
Rising cases of cancer across the globe
The treatment, detection, and prevention of different cancers have made significant strides in recent years. Cancer is treated using surgery, chemotherapy, radiation, and biological and hormonal therapy. Doxorubicin is a frequently prescribed chemotherapy medication that is used to treat several tumor types. Oxidative stress has an impact on the kidney, heart, and brain. Chemotherapy drug resistance in metastatic breast cancer is still a problem for effective treatment. As a result, this element is fueling the medical radiation detection market.
Growing utilization of radiation therapy and nuclear medicine
Instrumentation, and IT, nuclear medicine procedures have drastically changed over the past ten years. The need for radiation detection, monitoring, and safety systems has increased due to the growing use of nuclear medicine in diagnosing and treating many diseases, including cancer and cardiovascular ailments. Gas-filled detectors, scintillation detectors, and semiconductor detectors are the different types used in nuclear medicine. In light of these factors, the growing usage of radiation therapy and nuclear medicine is predicted to support the market expansion.
Market Restraining Factors
Strict regulatory mandates
The Nuclear Regulatory Commission (NRC), National Council on Radiation Protection (NCRP), Food and Drug Administration (FDA), International Commission on Radiological Protection (ICRP), and the US Department of Energy (DOE) have established radiation protection standards that are recognized by the national authorities. In addition, these departments have established multiple protocols to approve medical radiation identification, monitoring, and safety products. Nevertheless, these rigorous regulations prolong the duration of the product approval procedure. Hence, with the strict safety regulations which can delay product launches and development are expected to hamper the market expansion.
Type Outlook
Based on type, the medical radiation detection market is characterized into gas-filled detectors, scintillators, and solid-state. The solid-state segment covered a considerable revenue share in the medical radiation detection market in 2022. Ionizing radiation can be found using solid-state detectors, which are quite effective since they can turn a significant part of incident radiation into an electrical signal. They can accurately detect radiation at very low levels due to this. For instance, the U.S. Nuclear Regulatory Commission asserts that solid-state detectors are superior to gas-filled detectors at identifying low-energy gamma rays.
Product Outlook
On the basis of product, the medical radiation detection market is classified into personal dosimeters, area process dosimeters, surface contamination monitors, and others. In 2022, the personal dosimeters segment witnessed the largest revenue share in the medical radiation detection market. Because of its qualities, including being portable and simple to use, personal dosimeters are growing in popularity. Workers working in areas where radiation exposure poses a concern have their exposure levels monitored by personal dosimeters.
End-Use Outlook
By end-use, the medical radiation detection market is divided into hospitals, ambulatory surgical centers, diagnostic imaging centers, and homecare. In 2022, the hospitals segment dominated the medical radiation detection market with the maximum revenue share. There is a rising need for medical imaging treatments like CT scans, X-rays, and PET scans. This is due to the growing elderly population and the rise in chronic diseases. Medical radiation detectors are crucial in these operations to ensure patients receive the proper dose of radiation and to guard against overexposure.
Regional Outlook
Region wise, the medical radiation detection market is analyzed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the North America region led the medical radiation detection market by generating the highest revenue share. This can be due to rising anxiety around the dangers that could be involved with being exposed to ionizing radiation during medical treatments. As a result, radiation safety is receiving increased attention from regulatory agencies and medical establishments. This has increased the need for medical radiation detectors to measure radiation levels correctly and improve patient safety.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include IBA Dosimetry GmbH, Mirion Technologies, Inc., Thermo Fisher Scientific, Inc., LANDAUER (Fortive Corporation), Polimaster Europe UAB, PTW Freiburg GmbH, ATOMTEX, Radiation Detection Company, MP Biomedicals, LLC (Valiant Co. Ltd), and Amray Group Ltd.
Strategies Deployed in Medical Radiation Detection Market
2023-Mar: Polimaster announced the launch of the new Polismart iOS app for iPhones and iPads. The launch aims to build a smarter way for the innovative operation of Polimaster products. The product is designed to offer users radiation exposure analytics and deeper insights.
2023-Feb: Mirion Technologies, Inc. collaborated with Flyability, a provider of Indoor drone solutions. Under this collaboration, the Mirion RDS-32 radiation survey meter would be combined with Flyability's Elios 3 indoor drone. This combination would allow nuclear operators to collect accurate radiation data remotely by drone, enabling nuclear personnel to stay safely outside of irradiated areas at the time of data collection.
2022-Sep: IBA S.A. collaborated with ScandiDos A.B., a technology company engaged in advanced Radiation Therapy Quality Assurance for radiation therapy dosimetry solutions. The alliance would allow the two businesses to operate together on product development, marketing, and product distribution in the specified markets for patient quality assurance for radiotherapy.
2022-May: IBA completed the acquisition of Modus Medical Devices Inc., a company specializing in phantoms for quality assurance for radiation therapy. This acquisition strengthens IBA's Dosimetry operations across North America and adds complete dosimetry 'phantom' suite on the market.
2021-Dec: Mirion Technologies, Inc. completed the acquisition of Computerized Imaging Reference Systems, Inc., a provider of medical imaging and radiation therapy phantoms serving the medical industry. The acquisition enhances patient outcomes and expands Mirion's Medical Segment.
2021-Nov: Mirion Technologies, Inc. took over CHP Dosimetry, a distributor of Dosimetry services. With this acquisition, Mirion would directly serve CHP Dosimetry's existing customers that would continue to utilize Mirion's strong dosimetry products.
2021-Oct: Mirion Technologies, Inc. acquired the Dosimetry Badge brand, a distributor of personal dosimeter badges. Following this acquisition, Mirion would strengthen its place in the US dosimetry market and serve existing Dosimetry Badge customers while offering them the choice to explore strong dosimetry options.
2021-Oct: IBA partnered with TRAD Tests & Radiations, a company offering a high level of service for all radiation testing, calculation, and analysis services. This partnership would allow the development of the latest radiation processing module based on TRAD's RayXpert 3D modeling and dose calculation technology.
2019-Mar: Thermo Fisher Scientific introduced Thermo Scientific Harshaw thermoluminescence dosimeter, a new dosimetry monitoring service. This launch allows medical and imaging facilities, laboratories, dental offices, and nuclear power plants. The products are created to allow facility operators to observe and track individual employees accumulated radiation dose with accuracy and precision.
Market Segments covered in the Report:
By Product
By Type
By End Use
By Geography
Companies Profiled
Unique Offerings from KBV Research